About

AboutHistory

History

2024.12

Selected as an Exhibitor at the 2025 CES (U.S.) Seoul Pavilion

2024.09

Selected for the DeepTech TIPS program by the Korean Ministry of SMEs and Startups ($1.2M)

2024.07-08

MOU signed with :

- ILIAS Biologics Inc. (South Korea)

- MDimmune Inc. (South Korea)

- Olix Pharmaceuticals Inc. (South Korea)

- PeopleBio Inc. (South Korea)

2024.04-05

Korean patent technology transfer completed

- Method of mixing materials using a microfluidic chip, method of synthesizing natural exosome-mimicking nano-vesicles using the same, and natural exosome-mimicking nano-vesicles synthesized thereby (10-2024-0055609)

- Artificial exosome composition design method and system, artificial exosome synthesis method using the same, and natural exosome-mimicking artificial exosome composition comprising the same (10-2024-0064575)

.

Selected for the National Project by the Korean Ministry of Food and Drug Safety ($0.5M)

.

MOU signed with :

- Naturwerk GmbH (Germany)

2024.03

MOU signed with :

- PlantForm Corp. (Canada)

2023.10

MOU signed with :

-KIST Europe FGmbH (Germany)

-One BioMed Pte. Ltd. (Singapore)

2023.09

Honored as Yonsei University’s Best Company in Early Startup Package by the Korean Ministry of SMEs and Startups

2023.01

Selected for the 2023–2024 Bio-Medical Technology Development Project by the Korean Ministry of Science and ICT

2022.10

Selected for the 2022-2023 KOICA (Korea International Cooperation Agency) Innovative Technology Program (SEED1)

2022.09

Korean patent technology transfer completed

- Tuberculosis diagnostic methods and kit technologies using biomarker

- Plant-derived exosome isolation method, thus isolated exosome, and cosmetic use thereof (10-2022-0145732)

2022.05

Secured guarantee from the Korea Technology Finance Corporation

Selected for the Early Startup Package by the Korean Ministry of SMEs and Startups

2022.03

U.S. patent technology transfer completed

- High efficiency particle separating apparatus and method (US 9,846,150 B2)

.

MOU signed with :

- Activon Co., Ltd. (South Korea)

- Korean Agency for Defense Development (South Korea)

- LFAnt MEDICAL (Canada)

.

Certification of Corporate Research Institute

2021.11

Certified as a Venture Company by the Korean Ministry of SMEs and Startups

2021.09

Corporate establishment of The DABOM Inc. Certified as a Small and Medium Enterprise by the Korean Ministry of SMEs and Startups

2021.05

Selected for the Preliminary Startup Package by the Korean Ministry of SMEs and Startups

2021.03

Selected as a Leading Startup University Laboratory-Based Preliminary Startup by the Korea Institute of Startup and Entrepreneurship Development

close